Content about New Jersey

August 9, 2013

Eight O'Clock Coffee today announced the company is overhauling its packaging design, refreshing its design with a modern and sleek red design, the company stated.

MONTVALE, N.J. — Eight O'Clock Coffee today announced the company is overhauling its packaging design, refreshing its design with a modern and sleek red design, the company stated. Additionally, the company is set to launch new varieties as well as a new consumer marketing push to be featured on air, online and will even hit the runway.

August 9, 2013

Actavis and Warner Chilcott have received approval from all necessary antitrust clearances for their merger from regulators outside the United States, the companies said.

 PARSIPPANY, N.J. — Actavis and Warner Chilcott have received approval from all necessary antitrust clearances for their merger from regulators outside the United States, the companies said Friday.

The drug makers said that the French Competition Authority had approved U.S.-based Actavis' acquisition of Ireland-based Warner Chilcott. The German Federal Cartel Office had previously approved the deal as well.

August 9, 2013

Amazon's grocery service might be making its way to New York next year, according to published reports.

SEATTLE – Amazon's grocery service might be making its way to New York next year, according to published reports.

Citing analysis from SunTrust analyst Robert Peck, EcommerceBytes.com reported that the Seattle-based online retailer may start offering Amazon Fresh in New York in 2014, based on his finding that the company had expanded into a New Jersey warehouse previously used by C&S Wholesale Grocers. 

August 9, 2013

In his new role leading the Mars Chocolate sales organization, LaBerge will oversee the strategy and execution of its retail management, customer account teams, field sales and customer development.

HACKETTSTOWN, N.J. — Mars Chocolate North America announced today that Rick LaBerge has joined the company as VP of sales. In his new role leading the Mars Chocolate sales organization, LaBerge will oversee the strategy and execution of its retail management, customer account teams, field sales and customer development. He serves as a member of the Mars Senior Management Team and will play an active role in industry events.

August 8, 2013

Campbell Soup Co. has completed the acquisition of Kelsen Group A/S, a producer of baked snacks, including the Kjeldsens and Royal Dansk brands, sold in 85 countries around the world.

CAMDEN, N.J. — Campbell Soup Co. has completed the acquisition of Kelsen Group A/S, a producer of baked snacks, including the Kjeldsens and Royal Dansk brands, sold in 85 countries around the world.

Based in Denmark, Kelsen is a provider in the assortment segment of the sweet biscuits category in China and Hong Kong, where growth in sweet biscuits is outpacing the growth of the $60 billion global sweet biscuits market.

August 8, 2013

Eisai announced that the Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous T-cell lymphoma.

WOODCLIFF LAKE, N.J. — Eisai Inc., announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous T-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process. It is currently in a pivotal trial intended to support its submission for approval.

August 6, 2013

Actavis has acquired global rights to a drug made by a Spanish company for fungal infections of the vagina, the companies said Tuesday.

PARSIPPANY, N.J. — Actavis has acquired global rights to a drug made by a Spanish company for fungal infections of the vagina, the companies said Tuesday.

Actavis and Palau Pharma announced that Actavis Specialty Brands had acquired right's to albaconazole, an orally administered antifungal for vulvo-vaginal candidiasis, onychomycosis and others. The drug, which Palau discovered, is currently in phase-2 clinical trials, and Actavis foresees a potential U.S. commercial launch of the drug in 2017.

August 5, 2013

Amneal Pharmaceuticals has introduced five new generic drugs, the company said.

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has introduced five new generic drugs, the company said.

The drugs launched are:

Potassium chloride extended-release capsules in the 750-mg strength and in bottle count sizes of 100, 500 and 1,000. The drug is a generic version of Nesher Pharmaceuticals' Micro-K10 ExtenCaps and used to treat potassium deficiency.

Sildenafil tablets in the 20-mg strength and in 90-count bottles. The drug is a generic version of Pfizer's Revatio, used to treat pulmonary arterial hypertension.

August 5, 2013

Church & Dwight is ready to make a significant investment behind its gummy line of vitamins, Jim Craigie, C&D executive chairman, CEO and interim president, told analysts.

EWING, N.J. — Church & Dwight is ready to make a significant investment behind its gummy line of vitamins, Jim Craigie, C&D executive chairman, CEO and interim president, told analysts Friday. "We'll increase in-store sampling by over 60% versus last year," he said, noting there is a significant growth opportunity within what is already a fast-growing category.  

August 2, 2013

Mars Chocolate North America announced a new addition to the Dove dark chocolate family with new Dove Mint & Dark Chocolate Swirl.

HACKETTSTOWN, N.J. — Today, Mars Chocolate North America announced a new addition to the Dove dark chocolate family with new Dove Mint & Dark Chocolate Swirl.

Dove Mint & Dark Chocolate is available in both large bars and individually wrapped Dove brand Promises. The suggested retail price is $1.99 and $3.49, respectively.

August 1, 2013

Reckitt Benckiser named Alexander Lacik, 48, to the position of president, Reckitt Benckiser North America, effective June 2013. Lacik reports directly to Rob de Groot, EVP Europe and North America, and will be a part of the ENA leadership team.

PARSIPPANY, N.J. — Reckitt Benckiser on Thursday named Alexander Lacik, 48, to the position of president, Reckitt Benckiser North America, effective June 2013. Lacik reports directly to Rob de Groot, EVP Europe and North America, and will be a part of the ENA leadership team.

In his new role, Lacik will be responsible for increasing RB's North American market share, creating new innovations in the health, home and hygiene space, and developing Reckitt's "Powerbrands."

July 31, 2013

The Natural Dentist, a line of therapeutic oral care products, and Dr. Susan Calderbank, a leading dentist in oral health for patients undergoing chemotherapy and head and neck radiation, announced a partnership to raise awareness about the oral complications of cancer treatments in a joint effort to help patients manage these often debilitating side effects.

MADISON, N.J. — The Natural Dentist, a line of therapeutic oral care products, and Dr. Susan Calderbank, a leading dentist in oral health for patients undergoing chemotherapy and head and neck radiation, today announced a partnership to raise awareness about the oral complications of cancer treatments in a joint effort to help patients manage these often debilitating side effects.

July 30, 2013

NutraFana Pharmaceuticals recently launched a probiotic formulated specifically for children called FloraTummys Probiotic Sprinkles.

NORTH BERGEN, N.J. — NutraFana Pharmaceuticals recently launched a probiotic formulated specifically for children called FloraTummys Probiotic Sprinkles. 

The product is formulated with Lactobacillus Acidophilus and Bifidobacterium Lactis and retails for a suggested $29.99 for a 30-day supply. 

July 30, 2013

Hisamitsu America, the manufacturer of Salonpas, an OTC pain patch that is FDA approved and clinically proven, announced the launch of Salonpas Deep Relieving Gel, a topical analgesic solution.

FLORHAM PARK, N.J. — Hisamitsu America, a division of Hisamitsu Pharmaceutical Co. Inc. and the manufacturers of Salonpas, an OTC pain patch that is FDA approved and clinically proven, last week announced the launch of Salonpas Deep Relieving Gel, a topical analgesic solution.

July 29, 2013

Actavis hopes to become the first to market a generic drug for treating chronic pain, the company said.

PARSIPPANY, N.J. — Actavis hopes to become the first to market a generic drug for treating chronic pain, the company said Monday.

Actavis said it had filed with the Food and Drug Administration for approval of tapentadol extended-release tablets in the 50-mg, 100-mg, 150-mg and 200-mg strengths. The drug is a generic version of Johnson & Johnson subsidiary Janssen Pharmaceuticals' Nucynta ER. The drug is used as a continuous, around-the-clock analgesic over a long period of time.

July 29, 2013

Actavis is launching new formulations of a drug used to treat tension headaches, the company said Monday.

PARSIPPANY, N.J. — Actavis is launching new formulations of a drug used to treat tension headaches, the company said Monday.

The drug maker announced new formulations for Fioricet (butalbital; acetaminophen; caffeine) capsules and Fioricet with Codeine that reduce the amount of acetaminophen from 325 mg to 300 mg. Actavis said the formulation would provide a safer treatment option for patients.

July 26, 2013

Anda VP purchasing Marc Falkin wrote in an email to coworkers and friends that he would begin working for Actavis as VP marketing, pricing and contract operations for the Parsippany, N.J.-based drug maker's generics business.

WESTON, Fla. — One of Anda's executives is moving to Actavis after 12 years at Anda.

Anda VP purchasing Marc Falkin has announced that he is leaving the company, and will join Actavis as VP marketing, pricing and contract operations for the Parsippany, N.J.-based drug maker's generics business. Anda executive director of purchasing Anthony Mihelich will assume Falkin's responsibilities in the interim.

 

July 26, 2013

A federal court has ruled in favor of generic drug maker Sandoz in a case involving a drug for multiple sclerosis, Sandoz said.

PRINCETON, N.J. — A federal court has ruled in favor of generic drug maker Sandoz in a case involving a drug for multiple sclerosis, Sandoz said.

Sandoz, the generics division of Switerland-based Novartis, said the U.S. Federal Circuit Court of Appeals invalidated nine patents owned by Israel-based Teva Pharmaceutical Industries covering the drug Copaxone (glatiramer acetate).

July 26, 2013

Grocer A&P, which emerged from bankruptcy about a year ago, is reportedly up for sale, according to The Wall Street Journal, who obtained an internal memo that is circulating to employees.

MONTVALE, N.J. — Grocer A&P, which emerged from bankruptcy about a year ago, is reportedly up for sale, according to The Wall Street Journal, who obtained an internal memo that is circulating to employees.

The WSJ reports that the memo, sent by chairman Gregory Mays, outlines several options for the company to fund its growth, including raising capital and refinancing. The memo also states that a sale of the company is possible.

July 25, 2013

The majority of employers in New York, New Jersey and Pennsylvania don't plan to change their hiring practices in response to Obamacare, according to a new survey.

TEANECK, N.J. — The majority of employers in New York, New Jersey and Pennsylvania don't plan to change their hiring practices in response to Obamacare, according to a new survey.

July 19, 2013

Health and beauty aid manufacturer CCA Industries, whose brands include Plus+White toothpastes and teeth whiteners and Nutra Nail nail care treatments, swung to a loss during the second quarter but expressed optimism for the fourth quarter.

EAST RUTHERFORD, N.J. — Health and beauty aid manufacturer CCA Industries, whose brands include Plus+White toothpastes and teeth whiteners and Nutra Nail nail care treatments, swung to a loss during the second quarter but expressed optimism for the fourth quarter.

July 18, 2013

Unilever’s Caress is celebrating the launch of its new Caress Tempting Whisper Fine Fragrance Elixir body wash by teaming up with La La Anthony, the star of “La La’s Full Court Life.”

ENGLEWOOD CLIFFS, N.J. — Unilever’s Caress is celebrating the launch of its new Caress Tempting Whisper Fine Fragrance Elixir body wash by teaming up with La La Anthony, the star of “La La’s Full Court Life.”

Anthony is joining the Caress Fabulistas — beauty and style experts known for flaunting what is fabulous — to show women nationwide how fragrance can inspire them to live fabulously every day. They are sharing top fashion and beauty trends, inspired by fragrance.

July 18, 2013

The Food and Drug Administration has approved a cholesterol drug made by Par Pharmaceutical Cos., the drug maker said Thursday.

WOODCLIFF LAKE, N.J. — The Food and Drug Administration has approved a cholesterol drug made by Par Pharmaceutical Cos., the drug maker said Thursday.

Par announced the approval of generic fenofibric acid delayed-release capsules in the 45-mg and 135-mg strengths. The drug is used to reduce triglycerides and increase "good" high-density lipoprotein cholesterol.

The drug is a generic version of AbbVie's Trilipix, which has sales of about $554 million per year, according to IMS Health.

 

July 18, 2013

Looking to promote MinuteClinic services and its clinical collaboration with Virtua, the companies are reaching out to residents in southern New Jersey via direct mailings.

WOONSOCKET, R.I., and MARLTON, N.J. — Looking to promote MinuteClinic services and its clinical collaboration with Virtua, the companies are reaching out to residents in southern New Jersey via direct mailings. “Where to go when you’re sick or injured. New options for quality, convenient care,” the mailing states. It also lists information for both MinuteClinic and Virtua clinic locations and highlights the fact that no appointment is needed.

July 17, 2013

Johnson & Johnson will be making a strong comeback across its portfolio of McNeil Consumer Healthcare recalled OTC products in the fourth quarter of this year.

NEW BRUNSWICK, N.J. — Johnson & Johnson will be making a strong comeback across its portfolio of McNeil Consumer Healthcare recalled OTC products in the fourth quarter of this year. And with a J&J pledge to partner with key retail partners "on strategic relationships that are rebuilding our relationships and supporting their health and wellness strategies," this fourth quarter will likely be more promotional all around.